Table 11.11

Adjusted Patient Survival, Heart Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	4,140	90.9%	0.4%	4,140	86.5%	0.5%	4,159	78.9%	0.6%	4,404	72.7%	0.7%
Primary Diagnosis	Coronary Artery Disease	1,779	91.0%	0.7%	1,779	86.7%	0.9%	1,884	77.7%	1.1%	2,081	72.1%	1.1%
	Cardiomyopathy	1,898	92.7%	0.6%	1,898	88.0%	0.8%	1,907	81.7%	0.9%	1,865	74.9%	1.0%
	Congenital Heart Disease	341	80.2%	2.9%	341	76.8%	3.1%	265	68.5%	3.8%	332	61.6%	3.7%
	Valvular Heart Disease	101	88.7%	3.1%	101	84.0%	3.6%	91	75.6%	4.4%	106	75.7%	4.1%
	Other	21	90.5%	6.2%	21	81.0%	8.3%	12	61.4%	14.5%	19	84.2%	8.1%
	Unknown	0	-	-	0	-	-	0	-	-	1	0.0%	0.0%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.